Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Characteristics of the study participants, colonisation and mortality

From: Molecular surveillance reveals widespread colonisation by carbapenemase and extended spectrum beta-lactamase producing organisms in neonatal units in Kenya and Nigeria

Characteristic

Ibadan n (%)

Kisumu n (%)

Total n (%)

Participants

24 (57.1)

18 (42.9)

42 (100.0)

Female

14 (58.3)

10 (55.6)

24 (57.1)

Very low birthweight (< 1500 g)

24 (100)

4 (22.2)

28 (66.7)

Extremely preterm (gestational age < 28 completed weeks)

1 (4.2)

5 (27.8)

6 (14.3)

Caesarean section delivery

13 (54.2)

6 (33.3)

19 (45.2)

Mother HIV positive

0 (0.0)

3 (16.7)

3 (8.6)

1 or more episodes of suspected sepsis

12 (50)

18 (100.0)

30 (71.4)

1 or more episodes of necrotising enterocolitis

5 (20.8)

1 (5.5)

6 (14.3)

ESBL colonised1

22 (91.6)

14 (77.8)

36 (85.7)

CPO colonised1

20 (83.3)

8 (44.4)

28 (66.7)

Uncolonized by antimicrobial-resistant organism1

0 (0.0)

2 (11.1)

2 (4.8)

Mortality in neonatal unit

5 (20.8)

7 (38.9)

12 (28.6)

  1. ESBL extended spectrum beta-lactamase, CPO carbapenemase producing organism
  2. 1At any time during admission